These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 7889196)

  • 1. Regional haemodynamic effects of the novel AT1 receptor antagonist, CV-11974, in conscious rats.
    Widdop RE; Li XC; Jarrott B
    Blood Press Suppl; 1994; 5():15-20. PubMed ID: 7889196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional hemodynamic effects of the AT1 receptor antagonist CV-11974 in conscious renal hypertensive rats.
    Li XC; Widdop RE
    Hypertension; 1995 Dec; 26(6 Pt 1):989-97. PubMed ID: 7490160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin type 1 receptor antagonists CV-11974 and EXP 3174 cause selective renal vasodilatation in conscious spontaneously hypertensive rats.
    Li XC; Widdop RE
    Clin Sci (Lond); 1996 Aug; 91(2):147-54. PubMed ID: 8795437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AT2 receptor-mediated vasodilatation is unmasked by AT1 receptor blockade in conscious SHR.
    Li XC; Widdop RE
    Br J Pharmacol; 2004 Jul; 142(5):821-30. PubMed ID: 15197103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of a centrally-mediated antihypertensive effect following acute or chronic central treatment with AT1-receptor antagonists in spontaneously hypertensive rats.
    Bunting MW; Widdop RE
    Br J Pharmacol; 1995 Dec; 116(8):3181-90. PubMed ID: 8719794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal protective effects of angiotensin II receptor I antagonist CV-11974 in spontaneously hypertensive stroke-prone rats (SHR-sp).
    Nakamura T; Honma H; Ikeda Y; Kuroyanagi R; Takano H; Obata J; Sato T; Kimura H; Yoshida Y; Tamura K
    Blood Press Suppl; 1994; 5():61-6. PubMed ID: 7889203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II receptor antagonist CV-11974 and cerebral blood flow autoregulation.
    Vraamark T; Waldemar G; Strandgaard S; Paulson OB
    J Hypertens; 1995 Jul; 13(7):755-61. PubMed ID: 7594439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential haemodynamic effects of endothelin receptor antagonist, SB 209670, in conscious hypertensive and normotensive rats.
    Bunting MW; Widdop RE
    Eur J Pharmacol; 1999 Sep; 381(1):13-21. PubMed ID: 10528129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candesartan normalizes exaggerated tubuloglomerular feedback activity in young spontaneously hypertensive rats.
    Brännström K; Morsing P; Arendshorst WJ
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S213-9. PubMed ID: 9892166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of candesartan on angiotensin II-induced renal vasoconstriction in rats and mice.
    Ruan X; Purdy KE; Oliverio MI; Coffman TM; Arendshorst WJ
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S202-7. PubMed ID: 9892164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the dual metallopeptidase inhibitor, MDL 100,240, on regional haemodynamic responses to vasoactive peptides in conscious rats.
    Gardiner SM; Kemp PA; Brunner-Ferber F; Bennett T
    Br J Pharmacol; 1997 Dec; 122(8):1687-93. PubMed ID: 9422815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of central amino acid neurotransmitters on the antihypertensive response to angiotensin blockade in spontaneous hypertension.
    Yamada K; Moriguchi A; Mikami H; Okuda N; Higaki J; Ogihara T
    J Hypertens; 1995 Dec; 13(12 Pt 2):1624-30. PubMed ID: 8903622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal responses of the nonclipped kidney of two-kidney/one-clip Goldblatt hypertensive rats to type 1 angiotensin II receptor blockade with candesartan.
    Cervenka L; Navar LG
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S197-201. PubMed ID: 9892163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological profile of a novel nonpeptide angiotensin II subtype 1 receptor antagonist, TCV-116.
    Nishikawa K; Inada Y; Shibouta Y; Wada T; Ojima M; Kubo K; Naka T
    Blood Press Suppl; 1994; 5():7-14. PubMed ID: 7889205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated angiotensin II generation and regulation in rat mesenteric arteries following nephrectomy.
    Shi SJ; Rakugi H; Higashimori K; Higaki J; Mikami H; Ogihara T
    Blood Press Suppl; 1994; 5():27-31. PubMed ID: 7889198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AT2 receptors contribute to acute blood pressure-lowering and vasodilator effects of AT1 receptor antagonism in conscious normotensive but not hypertensive rats.
    Duke LM; Evans RG; Widdop RE
    Am J Physiol Heart Circ Physiol; 2005 May; 288(5):H2289-97. PubMed ID: 15615839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemodynamic effects of losartan and the endothelin antagonist, SB 209670, in conscious, transgenic ((mRen-2)27), hypertensive rats.
    Gardiner SM; March JE; Kemp PA; Mullins JJ; Bennett T
    Br J Pharmacol; 1995 Oct; 116(4):2237-44. PubMed ID: 8564254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced involvement of endothelin in the haemodynamic sequelae of endotoxaemia in conscious, hypertensive, transgenic ((mRen-2)27) rats.
    Gardiner SM; Kemp PA; March JE; Bennett T
    Br J Pharmacol; 1998 Apr; 123(7):1403-8. PubMed ID: 9579736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glomerular dimensions in spontaneously hypertensive rats: effects of AT1 antagonism.
    Kett MM; Alcorn D; Bertram JF; Anderson WP
    J Hypertens; 1996 Jan; 14(1):107-13. PubMed ID: 12013482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of an angiotensin II receptor antagonist, TCV-116, on cardiac hypertrophy and coronary circulation in spontaneously hypertensive rats.
    Takeda K; Fujita H; Nakamura K; Uchida A; Tanaka M; Itoh H; Nakata T; Sasaki S; Nakagawa M
    Blood Press Suppl; 1994; 5():94-8. PubMed ID: 7889211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.